Science Explorer Back to mapMap

Most cited papers from Protein Metrics (United States)

What are the most cited papers from Protein Metrics (United States)?

The most cited paper from Protein Metrics (United States) is "Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration" (Karel G.M. Moons, Douglas G. Altman, Johannes B. Reitsma et al., 2015), with 5,388 citations. Next come "A manifesto for reproducible science" (3,631) and "Redefine statistical significance" (2,853).

Showing 50 of 59 papers. Every paper with more than 123 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration Karel G.M. Moons, Douglas G. Altman, Johannes B. Reitsma et al. · Annals of Internal Medicine Open access 5 Jan 2015 5,388
2 A manifesto for reproducible science Marcus Robert Munafo, Brian A. Nosek, Dorothy Bishop et al. · Nature Human Behaviour Open access 10 Jan 2017 3,631
3 Redefine statistical significance Daniel Jacob Benjamin et al. · Nature Human Behaviour Open access 31 Aug 2017 2,853
4 Stream denitrification across biomes and its response to anthropogenic nitrate loading Patrick J. Mulholland et al. · Nature Mar 2008 1,343
5 Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies Myura Nagendran, Yang Chen, Christopher A. Lovejoy et al. · BMJ ReviewOpen access 25 Mar 2020 1,153
6 CONSORT 2025 statement: updated guideline for reporting randomised trials Sally Hopewell et al. · BMJ Open access 14 Apr 2025 988
7 How to Make More Published Research True John P. A. Ioannidis · PLoS Medicine Open access 21 Oct 2014 791
8 Empirical assessment of published effect sizes and power in the recent cognitive neuroscience and psychology literature Dénes Szűcs, John P. A. Ioannidis · PLoS Biology Open access 2 Mar 2017 781
9 Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices Vinay K. Prasad, John P. A. Ioannidis · Implementation Science Open access 8 Jan 2014 734
10 Use of the Extreme Groups Approach: A Critical Reexamination and New Recommendations. Kristopher J. Preacher, Derek D. Rucker, Robert C. MacCallum et al. · Psychological Methods Open access 2005 733
11 Byonic: Advanced Peptide and Protein Identification Software Marshall W. Bern, Yong Joo Kil, Christopher H. Becker · Current Protocols in Bioinformatics Open access Dec 2012 703
12 Why Most Clinical Research Is Not Useful John P. A. Ioannidis · PLoS Medicine Open access 21 Jun 2016 669
13 Process-Based Ecological River Restoration: Visualizing Three-Dimensional Connectivity and Dynamic Vectors to Recover Lost Linkages G. Mathias Kondolf, Andrew J. Boulton, Scott J. O'Daniel et al. · Ecology and Society Open access 2006 535
14 Transparency and reproducibility in artificial intelligence Benjamin Haibe‐Kains et al. · Nature Open access 14 Oct 2020 531
15 Meta-research: Evaluation and Improvement of Research Methods and Practices John P. A. Ioannidis, Daniele Fanelli, Debbie Drake Dunne et al. · PLoS Biology Open access 2 Oct 2015 516
16 Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention John P. A. Ioannidis, Marcus Robert Munafo, Paolo Fusar‐Poli et al. · Trends in Cognitive Sciences ReviewOpen access 21 Mar 2014 511
17 Assessing scientists for hiring, promotion, and tenure David Moher, Florian Naudet, Ioana A. Cristea et al. · PLoS Biology Open access 29 Mar 2018 499
18 Sample size evolution in neuroimaging research: An evaluation of highly-cited studies (1990–2012) and of latest practices (2017–2018) in high-impact journals Dénes Szűcs, John P. A. Ioannidis · NeuroImage Open access 15 Jul 2020 481
19 How to Read a Systematic Review and Meta-analysis and Apply the Results to Patient Care Mohammad Hassan Murad, Víctor M. Montori, John P. A. Ioannidis et al. · JAMA Open access 8 Jul 2014 464
20 Forecasting for COVID-19 has failed John P. A. Ioannidis, Sally Cripps, Martin A. Tanner · International Journal of Forecasting Open access 25 Aug 2020 454
21 SPIRIT 2025 statement: updated guideline for protocols of randomised trials An‐Wen Chan et al. · BMJ Open access 28 Apr 2025 403
22 A standardized citation metrics author database annotated for scientific field John P. A. Ioannidis, Jeroen Baas, Richard Klavans et al. · PLoS Biology Open access 12 Aug 2019 369
23 CONSORT 2025 Statement Sally Hopewell et al. · JAMA Open access 14 Apr 2025 341
24 How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure Huseyin Naci, Maximilian Salcher‐Konrad, Sofia Dias et al. · British Journal of Sports Medicine ReviewOpen access 18 Dec 2018 333
25 Meta-research: Why research on research matters John P. A. Ioannidis · PLoS Biology Open access 13 Mar 2018 331
26 Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters John P. A. Ioannidis, Cathrine Axfors, Despina G. Contopoulos‐Ioannidis · Environmental Research Open access Jul 2020 322
27 Mapping risk factors for depression across the lifespan: An umbrella review of evidence from meta-analyses and Mendelian randomization studies Cristiano André Köhler, Evangelos Evangelou, Brendon Stubbs et al. · Journal of Psychiatric Research Open access 25 May 2018 316
28 Systematic evaluation of the associations between environmental risk factors and dementia: An umbrella review of systematic reviews and meta‐analyses Vanesa Bellou, Lazaros Belbasis, Ioanna Tzoulaki et al. · Alzheimer s & Dementia ReviewOpen access 3 Sep 2016 307
29 Misconduct Policies, Academic Culture and Career Stage, Not Gender or Pressures to Publish, Affect Scientific Integrity Daniele Fanelli, Rodrigo Costas, Vincent Larivière · PLoS ONE Open access 17 Jun 2015 277
30 CONSORT 2025 statement: updated guideline for reporting randomized trials Sally Hopewell et al. · Nature Medicine Open access 14 Apr 2025 271
31 Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study Simon P.L. Travis, Silvio Danese, Limas Kupčinskas et al. · Gut Open access 22 Feb 2013 263
32 Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic? Rafael Dal‐Ré, Perrine Janiaud, John P. A. Ioannidis · BMC Medicine Open access 3 Apr 2018 260
33 Patient Satisfaction as a Possible Indicator of Quality Surgical Care Heather G. Lyu, Elizabeth Collens Wick, Michael Gene Housman et al. · JAMA Surgery Apr 2013 246
34 Updated science-wide author databases of standardized citation indicators John P. A. Ioannidis, Kevin W. Boyack, Jeroen Baas · PLoS Biology Open access 16 Oct 2020 237
35 The Impact of Customer Satisfaction on Share-of-Wallet in a Business-to-Business Environment Timothy Lee Keiningham, Tiffany Perkins‐Munn, Heather K. Evans · Journal of Service Research Aug 2003 236
36 The infection fatality rate of COVID-19 inferred from seroprevalence data John P. A. Ioannidis · medRxiv PreprintOpen access 19 May 2020 228
37 Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey Lars G. Hemkens, Despina G. Contopoulos‐Ioannidis, John P. A. Ioannidis · BMJ Open access 8 Feb 2016 227
38 Toward a policy ecology of implementation of evidence-based practices in public mental health settings Ramesh Raghavan, Charlotte Lyn Bright, Amy L Shadoin · Implementation Science Open access 16 May 2008 227
39 Exploration, Inference, and Prediction in Neuroscience and Biomedicine Danilo Bzdok, John P. A. Ioannidis · Trends in Neurosciences ReviewOpen access 23 Feb 2019 222
40 Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published inThe BMJandPLOS Medicine Florian Naudet, Charlotte Sakarovitch, Perrine Janiaud et al. · BMJ Open access 13 Feb 2018 217
41 Predicting declines in physical function in persons with multiple chronic medical conditions: What we can learn from the medical problem list Elizabeth A. Bayliss, Martha S. Bayliss, John E. Ware et al. · Health and Quality of Life Outcomes Open access 7 Sep 2004 214
42 Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic John P. A. Ioannidis · European Journal of Clinical Investigation Open access 7 Oct 2020 212
43 Researchers’ Individual Publication Rate Has Not Increased in a Century Daniele Fanelli, Vincent Larivière · PLoS ONE Open access 9 Mar 2016 210
44 Next-generation systematic reviews: prospective meta-analysis, individual-level data, networks and umbrella reviews John P. A. Ioannidis · British Journal of Sports Medicine Review 21 Feb 2017 191
45 CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials Sally Hopewell et al. · BMJ Open access 14 Apr 2025 190
46 How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation John P. A. Ioannidis, Betty Y.S. Kim, Alan Trounson · Nature Biomedical Engineering Open access 30 Oct 2018 171
47 Guidance to best tools and practices for systematic reviews Kat Kolaski, Lynne Romeiser Logan, John P. A. Ioannidis · Systematic Reviews ReviewOpen access 8 Jun 2023 167
48 Multiple Citation Indicators and Their Composite across Scientific Disciplines John P. A. Ioannidis, Richard Klavans, Kevin W. Boyack · PLoS Biology Open access Jul 2016 163
49 Dynamics of co-authorship and productivity across different fields of scientific research Austin J. Parish, Kevin W. Boyack, John P. A. Ioannidis · PLoS ONE Open access 10 Jan 2018 161
50 Assessment of transparency indicators across the biomedical literature: How open is open? Stylianos Serghiou, Despina G. Contopoulos‐Ioannidis, Kevin W. Boyack et al. · PLoS Biology Open access Mar 2021 155

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.